CCIP and FDA forge partnership for a more competitive local cosmetics industry


The Philippine beauty industry is poised for a significant boost thanks to a budding partnership between the Chamber of Cosmetics Industry of the Philippines (CCIP) and the Food and Drug Administration (FDA). This collaboration was solidified during a recent induction and courtesy call, where both parties discussed key challenges and opportunities for local cosmetics companies.

The induction and courtesy call was held on February 20, 2024 at Discovery Suites, Sta. Maria Room. The oath of induction was facilitated by FDA’s Center for Cosmetics and Household /Urban Hazardous Substances Regulation and Research (CCHUHSRR) Director Engr. Ana Trinidad Rivera, while the pledge of commitment was led by FDA Director General (DG) Dr. Samuel Zacate.

022224CCIPFDA1.jpg
CCHUHSRR’s Director, Engr. Ana Rivera, leads the oath of induction for the CCIP 2024 Board of Trustees.

Bridging the gap: Industry advocacy and information sharing

The CCIP acts as the unified voice of the industry, advocating for favorable policies and regulations that foster growth. As Christine Reyes, CCIP President, states, "It was a fruitful meeting. We see that the FDA recognizes the industry's needs and pain points." This collaborative spirit paves the way for constructive discussions and potential solutions, envisioning a sustainable partnership for the industry's benefit.

Focus on innovation: The F-Pop initiative

One of the key areas of collaboration is the "F-Pop Initiative," a joint project between FDA and Ministry of Food and Drug Safety (MFDS) Korea in promoting "functional cosmetics." Dr. Samuel Zacate, FDA Director General, acknowledges the challenge of keeping up with neighboring countries like South Korea, China, and Japan, but emphasizes, "It's a challenge that the FDA wants to help tackle with the local cosmetics industry." The F-Pop Initiative aims to make the Philippines more competitive in terms of product innovation by facilitating the development and approval of these specialized cosmetics.

022224CCIPFDA2.jpg
From left (first row): FDA Atty. III Pamela Angeline Sevilla; Executive Assistant to DG, Daniella Nicole De Vera; FDA DG, Dr. Samuel Zacate; CCHUHSRR Director, Engr. Ana Trinidad Rivera. From left (second row): CCIP Board of Trustees’ Diego Buenaflor, Dennies Ladia, Denice Sy, William Gilbert Mateo, Dr. Janina Tan, Rachel Manzano, Christine Reyes, Jacqueline Lim, Linda Yu, Jenny Nunez, and Camille Buenaventura.

Building a stronger industry together

The meeting brought together key representatives from both sides, including Dr. Zacate, Engr. Rivera, and Ms. Reyes, alongside other CCIP officers and FDA officials. This diverse group signifies the commitment to open communication and collaboration.

By focusing on advocacy, information sharing, and initiatives like the F-Pop Initiative, the CCIP-FDA partnership holds immense potential to empower local cosmetics companies, fostering a more competitive and innovative industry landscape. This, in turn, can lead to increased economic opportunities, job creation, and ultimately, a wider range of high-quality cosmetic products for Filipino consumers.